Brimonidine

Product Name: Brimonidine
Grade: IP / BP / USP
Therapeutic Category: Antiglaucoma
CAS No: 70359-46-5
Other Name: Brimonidine Tartrate
COA: Available
MSDS: Available

Brimonidine is a drug used to treat open-angle glaucoma or ocular hypertension, and as a gel, Mirvaso, for facial skin redness in rosacea.

Appearance-	White to slightly yellowish powder
Solubility-	Soluble in water, slightly souluble in methanol
Identification-	HNMR,HPLC
PH-	3.0~4.5
Melting point-	205°C~210°C
Specific rotation-	+ 9.0° ~ + 10.5°
Loss on drying-	≤0.5%
Residue on ignition-	≤ 0.1%
Heavy metals-	≤10 ppm
Related substances-	Single impurity ≤0.2%
Related substances-	Total impurities ≤0.5%
Assay(HPLC)-	99%~101%
Total aerobic microbial count-	Total bacterial count <100cfu/gr
Total aerobic microbial count-	Total fungal<10cfu/gr

Packaging details:

Packaging details:	25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Storage:	Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat
Shelf Life:	5 years if sealed and store away from direct sun light.